| |
|
|
|
|
|
|
|||
|
Blood, 1 December 2004, Vol. 104, No. 12, pp. 3618-3623. Prepublished online as a Blood First Edition Paper on July 29, 2004; DOI 10.1182/blood-2004-06-2312.
Submitted June 17, 2004
Department of Genetic Medicine and Development, University Medical School, Geneva, Switzerland; Division of Angiology and Hemostasis, University Hospital, Geneva, Switzerland * Corresponding author; email: Marguerite.Arbez{at}medecine.unige.ch.
Congenital afibrinogenemia, the most severe form of fibrinogen deficiency, is characterized by the complete absence of fibrinogen. The disease is caused by mutations in one of the three fibrinogen genes FGG, FGA and FGB, clustered on the long arm of human chromosome 4. The majority of cases are due to null mutations in the FGA gene although one would expect the three genes to be equally implicated. However, most patients studied so far are of Caucasian origin, and therefore the identification of causative mutations in non-European families is necessary to establish if this finding holds true in all ethnic groups. In this study, we report the identification of a novel nonsense mutation (Arg134X) in the FGG gene responsible for congenital afibrinogenemia in ten patients from Lebanon. Expression studies in COS-7 cells demonstrated that the Arg134X codon, which is encoded by adjacent exons (TG-intron 4-A) affected neither mRNA splicing nor stability, but led to the production of an unstable, severely truncated fibrinogen gamma-chain which is not incorporated into a functional fibrinogen hexamer.
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2004 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||